{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:03:46Z","timestamp":1789419826733,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013778","name":"Appendix Cancer Pseudomyxoma Peritonei Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008730","name":"Kreftforeningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejso.2026.111873","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:01:54Z","timestamp":1778284914000},"page":"111873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Limited clinical utility of mutation-based circulating tumor DNA detection in pseudomyxoma peritonei"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5751-9549","authenticated-orcid":false,"given":"Annette","family":"Torgunrud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3332-8427","authenticated-orcid":false,"given":"Ben","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thale Andrea","family":"Nilsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina Katrine","family":"Nitschke Marcussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9851-1866","authenticated-orcid":false,"given":"Vegar J","family":"Dagenborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7277-6612","authenticated-orcid":false,"given":"Christin","family":"Lund-Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7409-0780","authenticated-orcid":false,"given":"Kjersti","family":"Flatmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.ejso.2026.111873_bib1","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2026.111873_bib2","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.ejso.2012.06.552","article-title":"Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in pseudomyxoma peritonei","volume":"38","author":"S\u00f8rensen","year":"2012","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2026.111873_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2020.6363","article-title":"The role of hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei after cytoreductive surgery","volume":"156","author":"Kusamura","year":"2021","journal-title":"JAMA Surg"},{"issue":"1","key":"10.1016\/j.ejso.2026.111873_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejso.2020.02.012","article-title":"Appendiceal tumours and pseudomyxoma peritonei: literature review with PSOGI\/EURACAN clinical practice guidelines for diagnosis and treatment","volume":"47","author":"Govaerts","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2026.111873_bib5","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1038\/s41591-024-03254-6","article-title":"ctDNA-based molecular residual disease and survival in resectable colorectal cancer","volume":"30","author":"Nakamura","year":"2024","journal-title":"Nat Med"},{"issue":"14","key":"10.1016\/j.ejso.2026.111873_bib6","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1158\/1078-0432.CCR-23-3660","article-title":"Minimal residual disease using a plasma-only circulating tumor DNA assay to predict recurrence of metastatic colorectal cancer following curative intent treatment","volume":"30","author":"Parikh","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejso.2026.111873_bib7","unstructured":"Torgunrud A, Lund-Andersen C, Davidson B, Marcussen IKN, Larsen SG, Dagenborg V, et al. High prevalence of KRAS and GNAS mutations in pseudomyxoma peritonei underscores opportunities for targeted therapeutic strategies. Pleura Peritoneum."},{"issue":"7","key":"10.1016\/j.ejso.2026.111873_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2024.108395","article-title":"Undetectable circulating tumor DNA confirms the inability of pseudomyxoma peritonei to systemic dissemination","volume":"50","author":"Villarejo Campos","year":"2024","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111873_bib9","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920928233","article-title":"The role of mucin cell-free DNA detection as a new marker for the study of acellular pseudomyxoma peritonei of appendicular origin by liquid biopsy","volume":"12","author":"Garc\u00eda-Olmo","year":"2020","journal-title":"Ther Adv Med Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2026.111873_bib10","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1517\/14656560903044974","article-title":"Comprehensive management of peritoneal surface malignancy using cytoreductive surgery and perioperative intraperitoneal chemotherapy: the Washington cancer institute approach","volume":"10","author":"Sugarbaker","year":"2009","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"10.1016\/j.ejso.2026.111873_bib11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","article-title":"A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the Peritoneal Surface Oncology Group International (PSOGI) modified Delphi process","volume":"40","author":"Carr","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111873_bib12","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1245\/s10434-022-12399-y","article-title":"Circulating tumor DNA is unreliable to detect somatic gene alterations in gastrointestinal peritoneal carcinomatosis","volume":"30","author":"Sullivan","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2026.111873_bib13","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/annonc\/mdx125","article-title":"Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients","volume":"28","author":"Vidal","year":"2017","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111873_bib14","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1186\/s12885-022-09922-5","article-title":"Liquid biopsy using ascitic fluid and pleural effusion supernatants for genomic profiling in gastrointestinal and lung cancers","volume":"22","author":"Wu","year":"2022","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.ejso.2026.111873_bib15","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1245\/s10434-018-6561-z","article-title":"Preoperative circulating tumor DNA in patients with peritoneal carcinomatosis is an independent predictor of progression-free survival","volume":"25","author":"Baumgartner","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2026.111873_bib16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1158\/1078-0432.CCR-24-2474","article-title":"The landscape of ctDNA in appendiceal adenocarcinoma","volume":"31","author":"White","year":"2025","journal-title":"Clin Cancer Res"},{"issue":"14","key":"10.1016\/j.ejso.2026.111873_bib17","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.7150\/thno.59644","article-title":"Dynamic monitoring of circulating tumor DNA to predict prognosis and efficacy of adjuvant chemotherapy after resection of colorectal liver metastases","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.ejso.2026.111873_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003620","article-title":"Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: a prospective cohort study","volume":"18","author":"Tie","year":"2021","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.ejso.2026.111873_bib19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41591-024-03216-y","article-title":"Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma","volume":"31","author":"Black","year":"2025","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.ejso.2026.111873_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.766","article-title":"Circulating tumor DNA methylation detection as biomarker and its application in tumor liquid biopsy: advances and challenges","volume":"5","author":"Li","year":"2020","journal-title":"MedComm"},{"issue":"8","key":"10.1016\/j.ejso.2026.111873_bib21","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1159\/000536219","article-title":"Genome-wide analysis of DNA methylation in pseudomyxoma peritonei originated from appendiceal neoplasms","volume":"102","author":"Takane","year":"2024","journal-title":"Oncology"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326004920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326004920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:46:29Z","timestamp":1781333189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326004920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0748798326004920"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111873","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Limited clinical utility of mutation-based circulating tumor DNA detection in pseudomyxoma peritonei","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111873","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111873"}}